Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).

Autor: Monsellato, Igor1 (AUTHOR) igor.monsellato@ospedale.al.it, Alongi, Filippo2 (AUTHOR), Bertocchi, Elisa2 (AUTHOR), Gori, Stefania2 (AUTHOR), Ruffo, Giacomo2 (AUTHOR), Cassinotti, Elisa3 (AUTHOR), Baldarti, Ludovica3 (AUTHOR), Boni, Luigi3 (AUTHOR), Pernazza, Graziano4 (AUTHOR), Pulighe, Fabio5 (AUTHOR), De Nisco, Carlo5 (AUTHOR), Perinotti, Roberto6 (AUTHOR), Morpurgo, Emilio7 (AUTHOR), Contardo, Tania8 (AUTHOR), Mammano, Enzo7 (AUTHOR), Elmore, Ugo9 (AUTHOR), Delpini, Roberto9 (AUTHOR), Rosati, Riccardo9 (AUTHOR), Perna, Federico10 (AUTHOR), Coratti, Andrea10 (AUTHOR)
Zdroj: BMC Cancer. 12/16/2019, Vol. 19 Issue 1, p1-7. 7p. 1 Diagram.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje